Tirzepatide is a medication used for the treatment of type 2 diabetes and has also shown positive effects on weight loss. It acts as a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, two hormones that help regulate blood glucose levels, appetite, and weight control.
Regarding weight loss, tirzepatide has been shown to help reduce appetite, increase satiety (the feeling of fullness), and improve blood sugar control, leading to a decrease in calorie intake and, consequently, weight loss.
Dosage and Use The dose of tirzepatide for weight loss typically starts at 5 mg weekly. Therefore, a 30 mg treatment equals 6 weeks of treatment. The dose can be gradually increased depending on the patient's response, always under the supervision of a healthcare professional.
Side effects Some common side effects of tirzepatide include nausea, vomiting, diarrhea, and abdominal pain. As with other weight loss medications, it is important to follow medical instructions and monitor the treatment to assess its safety and effectiveness.
